Aims The aim of the study was to obtain further information regarding the modes of action of doxazosin, naftopidil and nifedipine on platelet function. Methods We conducted an in vitro study of drug influences on adrenaline and collagen-induced mobilization of platelet calcium. Results In the presence of fibrinogen (300 mg ml −1 ) both collagen (5 mg ml −1 ) and Conclusions These data indicate that the a 1 -adrenoreceptor blockers, naftopidil and doxazosin, inhibit Ca 2+ mobilization, this mechanism being possibly the means whereby these drugs inhibit platelet aggregation.
Introduction tion [15] . Using a more sensitive experimental system for assessing platelet aggregation we demonstrated that naftopidil Platelet activity is increased in hypertension and may contribute to the increased cardiovascular complications, i.e. and, to a lesser extent, doxazosin, at pharmacological concentrations, inhibited aggregation induced by subthrombosis and atherosclerosis, commonly observed in this condition [1, 2] . It has been reported that various antithreshold concentrations of adrenaline (the threshold concentration being defined as the minimum concentration hypertensive drugs reduce platelet sensitivity and therefore by extrapolation, presumably thrombosis [2] . For example, of agonist sufficient to induce secondary irreversible aggregation) in combination with subthreshold concentrations of a 2 -adrenoreceptor antagonists, b-adrenoreceptor blockers and calcium antagonists all interfere with platelet aggregation collagen, serotonin or ADP [15] . Additionally, but less markedly, naftopidil inhibited platelet aggregation induced [3] [4] [5] [6] [7] [8] [9] . a 1 -Adrenoreceptor blockers, e.g. prazosin, urapidil and doxazosin also inhibit platelet aggregation [10] [11] [12] [13] [14] [15] . In by adrenaline alone and to a lesser extent, serotonin. The results obtained with a 1 -adrenoreceptor antagonists are addition, we have reported that the experimental a 1 -paradoxical since firstly, platelets are not thought to possess a 1 -adrenoreceptors and secondly, platelet aggregation blockers produce their inhibitory effects on platelet function [20] as modified by Cooper et al. [21] in which prostacyclin (PGI 2 ) is omitted. Aequorin loading was conducted at room through other mechanisms.
One possible mechanism is that of intracellular calcium temperature (22°C) as follows. The volume of the platelet suspension was determined (typically 100 ml) and aequorin mobilization. The mobilization of intra-platelet calcium is a prerequisite for platelet activation [17, 18] . Increases in (300 mg in 15 ml EGTA solution) added. DMSO was then added in three equal volumes (final concentration 6%, v/v) platelet free Ca 2+ cause the activation of various mechanisms associated with platelet activation. These include the at 2 min intervals with stirring. After the addition of the final aliquot of DMSO, the cells were incubated for a activation of phospholipase A 2 , an enzyme which regulates arachidonic acid and prostaglandin synthesis, the activation further 4 min whereupon they were transferred to a 1.5 ml microcentrifuge tube, diluted with 1 ml of the HEPESof Ca 2+ dependent proteases (calpains) and mechanisms mediating conformational changes of cytoskeletal proteins buffered saline in which the EGTA was omitted. Platelets were sedimented by centrifugation (12,000 g, 15 s) and the [17, 18] .
In light of the central role played by Ca 2+ mobilization washing procedure repeated twice. Finally the platelets were resuspended in the same solution and diluted to a platelet in platelet activation, the decision was therefore made to examine the effects of naftopidil and doxazosin, in comparicount of 300×10 9 platelets l −1
. CaCl 2 and MgCl 2 were then added to give a final concentration of 1 mm. Before son with the well known Ca 2+ channel blocker, nifedipine, on this process. Thus, the aim was to obtain further commencement of experiments platelets were allowed to equilibrate for 20 min. information regarding the modes of action of a 1 -adrenoreceptor antagonists on platelet function.
Measurement of platelet aggregation and calcium mobilization Methods
Platelet aggregation and aequorin luminescence were measured simultaneously using a lumi-aggregometer (PICA, Chemicals
Chrono-Log Corp, Havertown, PA, USA). Samples of washed platelet suspension (800 ml) were Adrenaline, fibrinogen, nifedipine and dimethylsulphoxide (DMSO) were purchased from the Sigma Chemical Co Ltd, mixed with fibrinogen solution (200 ml, final concentration, 300 mg ml −1 ), previously prepared by suspension of 100 mg Poole, UK. Collagen fibrils were from Nycomed Arzneimittel, Munich, Germany. Aequorin was obtained of fibrinogen in 4 ml deionised water followed by dialysis vs HEPES-buffered saline (minus EGTA) and determination from Friday Harbor Photoproteins, Friday Harbor, WA, USA. Naftopidil was supplied by Asta Pharma, Frankfurt, of the protein concentration of the solution, and incubated for 1 min at 37°C. Drug vehicle (10 ml) or drug solution Germany and its solutions prepared in dimethyl formamide acidified with acetic acid (3.251 v/v) followed by dilution was then added and the incubation continued for 1 min whereupon collagen (5 mg ml −1 ) or adrenaline with distilled water, as previously described [15] . Doxazosin mesylate came from Pfizer Ltd, Sandwich UK and its (16 mm) was added to stimulate platelet aggregation. As previously described [15] naftopidil and doxazosin were solutions prepared in distilled water. Nifedipine solutions were prepared in DMSO and diluted with distilled water to tested at four concentrations. The lowest drug concentrations were equivalent to reported therapeutic plasma free concenthe desired concentrations.
trations but without taking account of their binding to protein (95-97% to plasma proteins for naftopidil and Subjects 98-99% for doxazosin) and were consequently probably considerably lower than the actual free concentrations. The Healthy non-smoking subjects aged 28-54 years, none of whom had taken any aspirin-like drugs during the previous highest concentrations were also equivalent to the therapeutic plasma free concentrations but after having taken 2 weeks. account of protein binding. Admittedly, our previous study of the effects of naftopidil and doxazosin on platelet function Blood collection, platelet preparation and aequorin loading was conducted using PRP rather than washed platelets, i.e. platelet preparations from which plasma proteins have been Antecubital venous blood was collected into acid citratedextrose anticoagulant (0.8% w/v citric acid; 2.2% w/v removed. Proteins which may bind drugs (i.e. fibrinogen and especially albumin) were, however, present in washed trisodium citrate; 2.4% w/v glucose), the anticoagulant5blood ratio being 159. Platelet-rich plasma (PRP) was platelet suspensions. Thus, it is our contention, as previously stated [15] , that the results obtained with the higher drug prepared by centrifugation of the anticoagulated blood and acidified to pH 6.0 with 1m citric acid to inhibit binding of concentrations are in fact probably more reflective of the situation occurring in vivo, if one considers the concentrations fibrinogen to its receptor [19] . The platelets were sedimented by centrifugation of the PRP (800 g, 20 min) and then of drug remaining in the medium following protein binding. Thus, naftopidil was tested at concentrations of 0.4, 2, 10 resuspended in a wash solution consisting of HEPES pH 7.3 (10 mm), NaCl (140 mm), KCl (2.7 mm), EGTA (5 mm), and 40 mm (equivalent to 0.157, 0.79, 3.93 and 15.7 mg l −1 ) and doxazosin at 0.3, 1.5, 7.5 and 30 mm (0.164, 0.82, 4.1 glucose (5 mm) and bovine serum albumin (1 mg ml −1 ).
The platelets were then re-sedimented by centrifugation and and 16.4 mg l −1 ). Nifedipine was tested at concentrations of 0.28, 1.4, 7 and 28 mm (0.097, 0.49, 2.42 and 9.7 mg l −1 ), resuspended in 50 ml of the HEPES buffered solution to produce a thick suspension. The platelets were then loaded 0.2-0.28 mm being equivalent to the reported therapeutic free drug plasma concentration [22] . with aequorin using a DMSO permeabilisation procedure Aggregation was expressed as a percentage of light transmission with 0% and 100% transmission being that recorded for the unstimulated platelet suspension and the suspension stimulated with 10 mg ml 
Results
Collagen (5 mg ml −1 ) and to a lesser extent adrenaline ] i induced by adrenaline were closely paralleled by inhibition of platelet aggregation (Figure 3a) , statistically significant results being obtained with 10 mm (83.4±2.9%, P<0.05, n=6) and 40 mm naftopidil (100±0%, P<0.05, n=6) but not 2 mm (25.7±11.4%, n=6) or 0.4 mm (4.3±7.3%, n=6). The IC 50 calculated for naftopidil with respect to adrenalineinduced aggregation was 3.8 mm.
Doxazosin produced statistically significant concentrationdependent inhibitions of the collagen stimulated rise in [Ca 2+ ] i of the same order as naftopidil (Figure 2b) ] i induced by adrenaline [23] . Thus, apart from the fact that fibrinogen was included in all platelet incubations, platelet pre-activation as a consequence of the cellular processing procedure used may, to some extent, explain the responses to adrenaline observed in this study, given that stimulators of adenylate cyclase, e.g. PGI 2 or PGE 1 , which are frequently included in platelet washing solutions to to the drugs tested were however obtained, indicating that variable and non-specific effects produced by platelet n=6). Statistically significant inhibitions of platelet aggreprocessing were minimal. gation were seen with 7.5 mm (35.8±12.6%, P<0.05, Both naftopidil and doxazosin reduced slightly and to n=6) and 30 mm (49.6±17.2%, P<0.05, n=6) doxazosin comparable extents the rise in platelet [Ca 2+ ] i stimulated by (Figure 3b) .
collagen. This was not paralleled by inhibitions of platelet As expected, nifedipine produced concentrationaggregation, except at the highest concentration (40 mm) of dependent inhibitions of collagen stimulated Ca 2+ mobilnaftopidil tested, essentially providing confirmation of our ization (1.4 mm, ] i caused by collagen [26] . Naftopidil produced marked concentration-dependent inhibitory effects on adrenaline-induced platelet [Ca 2+ ] i mobilization and aggregation, far in excess of those observed on collagen stimulation, whilst doxazosin was less potent in its effects. Platelet aggregation was also inhibited by both drugs, albeit to a greater extent by naftopidil. The fact that aggregation, supports our proposal that plasma protein inhibited both collagen stimulated platelet Ca 2+ mobilization 883-899. and aggregation in a concentration-dependent manner. in vitro platelet studies which have demonstrated inhibitory
The potentiation of adrenaline-induced in vitro platelet effects for drugs have often been followed up by in vivo
